Over the past year, IBM has shifted from traditional IT services into an AI-led growth strategy, moving away from large language model competition to focus on an enterprise AI platform and data orchestration. The company completed its acquisition of Confluent, which management expects to be accretive to adjusted EBITDA within 12 months and contribute positive free cash flow by year two. IBM is targeting its fourth consecutive year of more than 5% annual free cash flow growth and has guided to approximately $14 billion in free cash flow for fiscal 2025, driven by higher-margin software sales and expanding enterprise AI workloads.

In a recent interview on Money Movers, CEO Arvind Krishna detailed IBM’s decision to absorb $600 million in incremental U.S. tariffs over the last 12 months rather than pass them on to clients. Krishna cited the move as part of a broader effort to maintain long-term client relationships and defend enterprise budgets under pressure. He noted geopolitics remain a key risk, but said IBM’s diverse global footprint—spanning over 175 countries—and decentralized supply-chain model helped mitigate disruption and stabilize margins in Q3 and Q4 of 2025.

As IBM approaches its Q4 earnings release, analysts point to continued momentum in AI and hybrid cloud services driving revenue growth in the high-single digits. Yet the stock trades at a premium multiple relative to peers in enterprise software, reflecting investor confidence in watsonx and Red Hat integrations. Risks include intensifying competition from hyperscale cloud providers and specialized AI startups, which could pressure license renewals and deal cycles. Consensus estimates call for mid-teens percentage growth in software revenues but flag potential headwinds in managed infrastructure services.

IBM has partnered with e&, the technology arm of a major Middle Eastern telecom, to deploy enterprise-grade agentic AI solutions powered by watsonx Orchestrate. The joint offering targets compliance, policy enforcement and risk management for regulated industries, leveraging automated workflows to reduce manual intervention by up to 40%. Pilot deployments across finance and healthcare clients are scheduled to begin in Q2 2026, with IBM projecting this collaboration to contribute $200 million in incremental software bookings over the next 18 months.